[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BR0202157A - Peptìdeo obtido de veneno escorpião para uso como agente hipotensivo - Google Patents

Peptìdeo obtido de veneno escorpião para uso como agente hipotensivo

Info

Publication number
BR0202157A
BR0202157A BR0202157-9A BR0202157A BR0202157A BR 0202157 A BR0202157 A BR 0202157A BR 0202157 A BR0202157 A BR 0202157A BR 0202157 A BR0202157 A BR 0202157A
Authority
BR
Brazil
Prior art keywords
amino acid
peptide obtained
scorpion venom
hypotensive agent
peptide
Prior art date
Application number
BR0202157-9A
Other languages
English (en)
Inventor
Adriano Monteiro De Ca Pimenta
Maria Elena De Li Perez-Garcia
Carlos Ribeiro Diniz
Robson Augusto Souza Do Santos
Pierre Edouard Bougis
Marie-France Eauclaire
Original Assignee
Univ Minas Gerais
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Minas Gerais filed Critical Univ Minas Gerais
Priority to BR0202157-9A priority Critical patent/BR0202157A/pt
Priority to PCT/BR2003/000073 priority patent/WO2003104274A1/en
Priority to AU2003229155A priority patent/AU2003229155A1/en
Priority to US10/517,097 priority patent/US7192925B2/en
Priority to DE60325227T priority patent/DE60325227D1/de
Priority to EP03724688A priority patent/EP1534743B1/en
Priority to AT03724688T priority patent/ATE417061T1/de
Publication of BR0202157A publication Critical patent/BR0202157A/pt
Priority to US11/687,785 priority patent/US20070275901A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43522—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from scorpions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds
    • Y10S530/856—Snakes; venom

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Insects & Arthropods (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

"PEPTìDEO OBTIDO DE VENENO ESCORPIãO PARA USO COMO AGENTE HIPOTENSIVO". A presente invenção se refere a uma família de peptídeos, os quais são derivados do veneno de escorpiões (a classificação taxonómica atual é como segue: Eukariota; Metazoa; Arthropoda, Chelicerata; Arachnida; Scorpiones) que atuam como agentes hipotensivos pela potencialização de Bradykinin.
BR0202157-9A 2002-06-07 2002-06-07 Peptìdeo obtido de veneno escorpião para uso como agente hipotensivo BR0202157A (pt)

Priority Applications (8)

Application Number Priority Date Filing Date Title
BR0202157-9A BR0202157A (pt) 2002-06-07 2002-06-07 Peptìdeo obtido de veneno escorpião para uso como agente hipotensivo
PCT/BR2003/000073 WO2003104274A1 (en) 2002-06-07 2003-06-09 Scorpion peptide as hypotensive agent
AU2003229155A AU2003229155A1 (en) 2002-06-07 2003-06-09 Scorpion peptide as hypotensive agent
US10/517,097 US7192925B2 (en) 2002-06-07 2003-06-09 Scorpion peptide as hypotensive agent
DE60325227T DE60325227D1 (pt) 2002-06-07 2003-06-09
EP03724688A EP1534743B1 (en) 2002-06-07 2003-06-09 Scorpion peptide as hypotensive agent
AT03724688T ATE417061T1 (de) 2002-06-07 2003-06-09 Scorpionpeptid als blutdrucksenkendes mittel
US11/687,785 US20070275901A1 (en) 2002-06-07 2007-03-19 Synthesis, modification and reduction of primary structure of hypotensive peptides present in scorpion venom for optimizing their use as a hypotensive medicament

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR0202157-9A BR0202157A (pt) 2002-06-07 2002-06-07 Peptìdeo obtido de veneno escorpião para uso como agente hipotensivo

Publications (1)

Publication Number Publication Date
BR0202157A true BR0202157A (pt) 2005-04-12

Family

ID=38750221

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0202157-9A BR0202157A (pt) 2002-06-07 2002-06-07 Peptìdeo obtido de veneno escorpião para uso como agente hipotensivo

Country Status (7)

Country Link
US (2) US7192925B2 (pt)
EP (1) EP1534743B1 (pt)
AT (1) ATE417061T1 (pt)
AU (1) AU2003229155A1 (pt)
BR (1) BR0202157A (pt)
DE (1) DE60325227D1 (pt)
WO (1) WO2003104274A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0202157A (pt) * 2002-06-07 2005-04-12 Univ Minas Gerais Peptìdeo obtido de veneno escorpião para uso como agente hipotensivo
WO2007137163A2 (en) * 2006-05-19 2007-11-29 Georgia Tech Research Corporation Abc transporter ligand
US8324158B2 (en) * 2006-07-14 2012-12-04 Georgia Tech Research Corporation Methods for inhibiting CLC-2 channel with GATX2

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4585757A (en) * 1984-07-27 1986-04-29 Texas Tech University Health Sciences Center Hypotensive active peptides
IL104419A0 (en) 1992-01-24 1993-05-13 Fmc Corp Insecticidally effective peptides
US5494895A (en) * 1993-07-22 1996-02-27 Merck & Co., Inc. Scorpion peptide margatoxin with immunosuppressant activity
US5741810A (en) * 1996-02-29 1998-04-21 Allergan Cyclopentane heptan(ene)oic acid, 2- heteroarylalkenyl derivatives as therapeutic agents
US6569891B1 (en) * 2000-05-19 2003-05-27 Brigham Young University Antihypertensive compound from Caesalpinia brasiliensis
BR0202157A (pt) * 2002-06-07 2005-04-12 Univ Minas Gerais Peptìdeo obtido de veneno escorpião para uso como agente hipotensivo

Also Published As

Publication number Publication date
AU2003229155A1 (en) 2003-12-22
EP1534743B1 (en) 2008-12-10
US7192925B2 (en) 2007-03-20
DE60325227D1 (pt) 2009-01-22
ATE417061T1 (de) 2008-12-15
WO2003104274A1 (en) 2003-12-18
EP1534743A1 (en) 2005-06-01
US20070275901A1 (en) 2007-11-29
US20060014928A1 (en) 2006-01-19

Similar Documents

Publication Publication Date Title
RU2008136324A (ru) Желудочно-кишечный пролиферативный фактор и его применения
ATE458054T1 (de) Menschliches parathyroidhormon, modifikationen, herstellung und verwendung
NO20074516L (no) Pattedyrcytokinlignende polypeptid-1
AR036196A1 (es) Agentes de contraste multimericos dirigidos a base de peptidos
BR0208183A (pt) Peptìdeo modificado por wt1
DK66391D0 (da) Terapeutisk virksomme peptider
WO2007097903A3 (en) Hiv fusion inhibitor peptides with improved biological properties
ATE278708T1 (de) Conotoxin peptid pviia
BR9810478A (pt) Análogos de hormÈnio glicoproteìna reticulados por dissulfeto e sua preparação e utilização
DE60238330D1 (de) Immunologisch bedeutende herpes-simplex-virus-antigene und verfahren für ihre verwendung
ATE455792T1 (de) Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon
DK1417222T3 (da) Isolerede polypeptider baseret på den neutraliserende epitop af p17-proteinet fra HIV egnet til vacciner samt neutraliserende anti-p17-antistoffer, der specifikt genkender nævnte neutraliserende epitop
EP0161007A3 (en) Retro - inverso c-terminal hexapeptide analogues of substance p
DE69736276D1 (de) Menschliche dnase resistent gegen actininhibitoren
ATE474589T1 (de) Angiogene peptide und ihre verwendungen
BR0202157A (pt) Peptìdeo obtido de veneno escorpião para uso como agente hipotensivo
ATE510008T1 (de) Entzündungshemmende peptide
ATE291033T1 (de) Therapeutische peptide
BR0014803A (pt) Peptìdeo, composição farmacêutica, uso de um ou mais dos peptìdeos, e, composição de diagnóstico
SE9700301D0 (sv) New compound
EA200100314A1 (ru) Пептидные фрагменты холерного экзотоксина в или энтеротоксина в в качестве адъювантов вакцины
DK1778271T3 (da) Peptid til behandling af herpesvirusinfektioner
EP1354893A3 (en) Physiologically active complex
ATE420890T1 (de) Isoleucyl-valyl-threonyl-asparaginyl-threonyl- threonin (ivtntt) enthaltende biologisch wirksame peptide
CA2530731A1 (en) Peptide having apoptosis-inhibiting activity

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4A ANUIDADE.

B08H Application fees: decision cancelled [chapter 8.8 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1980 DE 16/12/2008 POR TER SIDO FEITA A CONCILIACAO DO PAGAMENTO DA ANUIDADE.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1980 DE 16/12/2008.

B08H Application fees: decision cancelled [chapter 8.8 patent gazette]

Free format text: REFERENTE AOS DESPACHOS 8.6 DA RPI 2016 DE 25/08/2009 E 8.11 DA RPI 2028 DE 17/11/2009 POR TEREM SIDO INDEVIDOS.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]